STOCK TITAN

If You Invested in Kailera Therapeutics, Inc. (KLRA)

Healthcare · Biotechnology · NASDAQ
Looking for the current price? See the KLRA quote & overview
$1,000 invested 1 Year Ago
N/A
Our prices start Apr 17, 2026
$1,000 invested 5 Years Ago
N/A
Our prices start Apr 17, 2026
$1,000 invested 10 Years Ago
N/A
Our prices start Apr 17, 2026

What $1,000 or $10,000 in KLRA Would Be Worth Now

Real historical value by amount invested and how long ago
If you invested 1 year ago 5 years ago 10 years ago Since Apr 17, 2026
$1,000 — — — $445 -55%
$10,000 — — — $4,454 -55%

Based on real historical closing prices adjusted for stock splits, without dividends, through the latest market close. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results.

Custom Calculation

Choose your own date and amount for KLRA

$1,000 Investment Over Time

KLRA vs S&P 500

Year-by-Year Returns

KLRA annual performance
Year Start Price End Price Annual Return Cumulative
2026Apr 17 to Nov 19 $26.00 $11.58 -55.5% -55.5%

About Kailera Therapeutics, Inc.

Healthcare · NASDAQ

Kailera Therapeutics, Inc. is a clinical-stage biotechnology company developing product candidates for obesity care. The company is focused on a pipeline intended to provide treatment options for people living with obesity, with development work centered on GLP-1 based mechanisms of action and multiple routes of administration. Its common stock trades on the Nasdaq Global Select Market under the symbol KLRA.

The company describes an obesity-first development strategy built around four clinical-stage product candidates. Its pipeline focus places Kailera in the biotechnology segment of metabolic and obesity therapeutics, where company value is tied to the advancement, regulatory development, financing, and potential commercialization of investigational medicines rather than to an established commercial product portfolio.

Kailera operates as a public operating company headquartered in Waltham, Massachusetts. The company completed its initial public offering in April 2026, selling common stock and listing on Nasdaq. Public-company records identify Kailera as an emerging growth company and show a Delaware corporate structure with common stock registered under Section 12(b) of the Exchange Act.

As a newly public clinical-stage biotechnology issuer, Kailera's corporate profile is defined by its obesity-focused research and development activities, equity-financed capital structure, public-market listing, and governance framework for a development-stage life sciences company.

Market Cap
$1.5B
Current Price
$11.58
View full KLRA overview

Frequently Asked Questions

Kailera Therapeutics, Inc. investment returns

How much would $1,000 invested in Kailera Therapeutics, Inc. be worth today?

Limited historical data is available for KLRA. Our price data for KLRA starts on Apr 17, 2026.

Has Kailera Therapeutics, Inc. outperformed the S&P 500?

Comparison data requires at least 10 years of trading history. Use the calculator above to compare KLRA performance over available time periods.

For informational and educational purposes only, not investment advice.